Focus on Co-digestion of waste activated sludge and food waste via yeast pre-fermentation and biochar supplementation: The optimization and mechanism.

Anaerobic digestion is a promising method to recover energy from waste, but the slow rate of fermentation hinders its application. Yeast pre-fermentation has been reported to enhance organic matter solubilization and ethanol production to promote syntrophic metabolism and methanogenesis. However, the pre-fermentation with yeast has not been optimized so far. In this study, the lab-scale experiment was conducted to optimize operational conditions, and a pilot-scale study was conducted to evaluate the combined strategy of yeast pre-fermentation and biochar supplementation. Results demonstrated that at a fermentation time of 6 h, temperature of 30 °C, and dry yeast dosage of 2‰, the highest ethanol production was achieved, which accounted for 6.2% of the total COD of pre-fermentation effluent of a mixture of waste-activated sludge and food waste. The methane yield of the pre-fermented waste averaged 161.3 mL/g VS/d, which was 18.7% higher than that of the control group without the yeast inoculation (135.8 mL/g VS/d). With supplementing biochar of 0.5 and 1 g/L, the average methane production was 27.8% and 36.4% higher than the control group, respectively. The volatile solid removal rate was over 10% higher than the control (58.2 ± 3.12%). Consistently, the electrochemical properties of sludge with biochar were significantly improved. A pilot-scale experiment further showed that the methane production with the yeast pre-fermentation and biochar supplementation reached 227 mL/g VS/d, 54.3% higher than that without yeast pre-fermentation and biochar. This study provided a feasible method to combine yeast pre-fermentation and biochar supplementation under optimal conditions, which effectively increased methane production during anaerobic digestion of organic waste.

Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.

BACKGROUND: Associations between blood pressure (BP) with age at onset of Huntington's disease (HD) have reported inconsistent findings. We used Mendelian randomization (MR) to assess effects of BP and lowering systolic BP (SBP) via the genes encoding targets of antihypertensive drugs on age at onset of HD. METHODS: Genetic variants from genome-wide association studies(GWAS) of BP traits and BP-lowering variants in genes encoding antihypertensive drugs targets were extracted. Summary statistics for age at onset of HD were retrieved from the GWAS meta-analysis of HD residual age at onset from the GEM-HD Consortium included 9064 HD patients of European ancestry (4417 males and 4,647 females). MR estimates were calculated using the inverse variance weighted method, supplemented by MR-Egger, weighted median, and MR-PRESSO methods. RESULTS: Genetically predicted SBP or diastolic BP increase was associated with a later age at onset of HD. However, after SBP/DBP was present as a covariate using multivariable MR method, no significant causal association was suggested. A 10-mm Hg reduction in SBP through variants in genes encoding targets of calcium channel blockers (CCB) was associated with an earlier age at onset of HD (ß=-0.220 years, 95% CI =-0.337 to -0.102, P = 2.42 × 10- 4). We did not find a causal association between angiotensin converting enzyme inhibitors and ß-blockers with the earlier HD onset. No heterogeneity and horizontal pleiotropy were identified. CONCLUSIONS: This MR analysis provided evidence that genetically determined SBP lowering through antihypertensive drugs might be associated with an earlier age at onset of HD. The results may have a potential impact on management of hypertension in the pre-motor-manifest HD population.

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.

Although viral hepatocellular carcinoma (HCC) is declining, nonviral HCC, which often is the end stage of nonalcoholic or alcoholic steatohepatitis (NASH, ASH), is on an upward trajectory. Immune checkpoint inhibitors (ICIs) that block the T cell inhibitory receptor PD-1 were approved for treatment of all HCC types. However, only a minority of HCC patients show a robust and sustained response to PD-1 blockade, calling for improved understanding of factors that negatively impact response rate and duration and the discovery of new adjuvant treatments that enhance ICI responsiveness. Using a mouse model of NASH-driven HCC, we identified peritumoral fibrosis as a potential obstacle to T cell-mediated tumor regression and postulated that antifibrotic medications may increase ICI responsiveness. We now show that the angiotensin II receptor inhibitor losartan, a commonly prescribed and safe antihypertensive drug, reduced liver and peritumoral fibrosis and substantially enhanced anti-PD-1-induced tumor regression. Although losartan did not potentiate T cell reinvigoration, it substantially enhanced HCC infiltration by effector CD8+ T cells compared to PD-1 blockade alone. The beneficial effects of losartan correlated with blunted TGF-ß receptor signaling, reduced collagen deposition, and depletion of immunosuppressive fibroblasts.

Enhancing anaerobic digestion of kitchen wastes via combining ethanol-type fermentation with magnetite: Potential for stimulating secretion of extracellular polymeric substances.

Magnetite, a common mineral that is abundant in the soils and sediments, has been widely documented to enhance the anaerobic digestion of organic wastes, whereas the mechanisms of magnetite promoting interspecies electron transfer are still unclear. In this study, under the conditions (ethanol-type fermentation) employed, magnetite stimulated the secretion of extracellular polymeric substances (EPS). Analysis of three-dimensional excitation emission matrix revealed that these EPS secreted in the presence of magnetite were primarily comprised of the redox-active organic functional groups. Electrochemical analysis showed that the EPS secreted with magnetite had the higher electron-accepting and electron-donating capacity than the EPS without magnetite. Syntrophomonas species capable of extracellularly transferring electron were enriched with supplementing magnetite. Together with the increased abundance of Methanospirillum and Methanobacterium species that could proceed direct interspecies electron transfer (DIET), the anaerobic digestion was likely improved due to the establishment of DIET with supplementing magnetite. As a result, anaerobic digestion of kitchen wastes was evidently enhanced. With decreasing the solid retention time to 30 d, the methane production rate only slightly declined to 18 ± 0.8 mL/g-VSS/d in the magnetite-supplemented digester, while almost no methane was detected in the digester without magnetite.

Effect of Yangqixue Qufengshi Recipe on rheumatoid arthritis model mice under different genetic backgrounds.

OBJECTIVE: To study the effect of Yangqixue Qufengshi Recipe (YQXQFS) on rheumatoid arthritis (RA) model mice under different genetic backgrounds. METHODS: Collagen Induced Arthritis (CIA) were established on HLA-DR4 transgenic (TG) mice and non-transgenic (NTG) mice, which partly were raised with YQXQFS, and the onset day of CIA, the level of type II collagen (CII)-reactive antibodies and the pathological scores of CIA were assessed. RESULTS: Under HLA-DR4 TG background (compared with NTG mice), the earlier onset day of CIA (11.22 +/- 3.35 days vs 16.56 +/- 4.75 days, P < 0.05) and higher level of CII-reactive antibodies (0.2274 +/- 0.1390 microg/ml vs 0.1101 +/- 0.0560 microg/ml, P < 0.05) were observed, but the pathological scores of CIA remained unchanged. YQXQFS could not influence the onset day of CIA and the level of CII-reactive antibodies, but had a certain effect on the total pathological scores (6.56 +/- 3.43 scores vs 11.11 +/- 5.64 scores) and bone erosion (0.22 +/- 0.44 scores vs 1.67 +/- 1.50 scores) of CIA on NTG mice (P < 0.05), NTG YQXQFS group compared with NTG experimental group. CONCLUSION: YQXQFS had a certain effect on RA model, but had no significant effect on HLA-DR4 related CIA.